Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions - (0004)

ESWT is considered experimental/investigational/unproven for ALL musculoskeletal conditions and is not covered under this policy (Cigna excludes musculoskeletal ESWT even though some devices have FDA PMA approvals for plantar fasciitis and lateral epicondylitis). Coverage may vary by plan—claims lacking covered diagnosis/procedure codes will be denied, providers must use current effective CPT codes, and you must follow the applicable benefit plan document for plan-specific requirements.

""Extracorporeal shock wave therapy (ESWT) is considered experimental, investigational or unproven for the treatment of ANY musculoskeletal condition."

Sign up to see full coverage criteria, indications, and limitations.